01.06.2022 • NewsBakelite

Bakelite Synthetics Buys Georgia-Pacific Chemicals

Bakelite Synthetics – formerly part of US resins producer Hexion – has closed its purchase of Georgia-Pacific Chemicals. Financial terms were not disclosed.

The acquisition gives Bakelite complementary resin and formaldehyde technology and end markets in the building materials, transportation, industrial, chemical intermediate and specialty resins space, as well as 11 chemical facilities employing about 600 people in the US and South America.

“We are excited about the opportunities that will result from the combined strengths of the two companies,” said Bakelite CEO JP Aucoin. “This acquisition enables us to deliver greater value to our customers through a broader product offering and expanded geographic reach. It also enables us to deliver on significant organic growth with the strong tailwinds in US residential construction.”

The combined company’s new headquarters will be based in Atlanta, Georgia – Bakelite’s former base was in Louisville, Kentucky – and will consist of approximately 1,500 employees and 21 manufacturing sites in 10 countries.

Bakelite was formed on May 1, 2021, from the $425 million purchase of Hexion’s phenolic resins business by private equity firms Black Diamond and Investindustrial.

Author: Elaine Burridge, Freelance Journalist

Photo by Patrick Schätz on Unsplash
Photo by Patrick Schätz on Unsplash

Company

Bakelite Synthetics

1040 Crown Pointe Parkway
30338 Atlanta
US

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.